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Abstract
Background: There has been a long standing interest in the identification of medicinal plants and derived natural
products for developing cancer therapeutics. Our study focuses upon pancreatic cancer, due to its high mortality
rate, that is attributed in part to the lack of an effective chemotherapeutic agent. Previous reports on the use of
medicinal plant extracts either alone or alongside conventional anticancer agents in the treatment of this cancer
have shown promising results. This work aims to investigate the therapeutic properties of a library of medicinal
plants from Bangladesh.
Methods: 56 extracts of 44 unique medicinal plants were studied. The extracts were screened for cytotoxicity
against the pancreatic adenocarcinoma cell line Panc-1, using a label-free biosensor assay. The top cytotoxic
extracts identified in this screen were tested on two additional pancreatic cancer cell lines (Mia-Paca2 and Capan-1)
and a fibroblast cell line (Hs68) using an MTT proliferation assay. Finally, one of the most promising extracts was
studied using a caspase-3 colorimetric assay to identify induction of apoptosis.
Results: Crude extracts of Petunia punctata, Alternanthera sessilis, and Amoora chittagonga showed cytotoxicity to
three cancer cell lines with IC50 values ranging between 20.3 - 31.4 μg/mL, 13.08 - 34.9 μg/mL, and 42.8 - 49.8 μg/mL,
respectively. Furthermore, treatment of Panc-1 cells with Petunia punctata was shown to increase caspase-3 activity,
indicating that the observed cytotoxicity was mediated via apoptosis. Only Amoora chittagonga showed low
cytotoxicity to fibroblast cells with an IC50 value > 100 μg/mL.
Conclusion: Based upon the initial screening work reported here, further studies aimed at the identification of
active components of these three extracts and the elucidation of their mechanisms as cancer therapeutics are
warranted.
Background
Pancreatic cancer is the fourth leading cause of cancer-
related death in both sexes in the United States [1].
Although Gemcitabine is the current first-line che-
motherapeutic administered for metastatic pancreatic
cancer, this line of treatment has been met with limited
survival and symptomatic outcomes [2,3] resulting in
research interest in exploring new alternatives for treat-
ment and prevention. Natural products play a dominant
role in the discovery of such new drugs, as over 60% of
approved drugs or those in late stages of development
(during 1989-1995) are of natural origin [4]. Examples
of clinically useful antitumor agents derived from plants
include paclitaxel, vincristine, and camptothecin. Many
of these plant-derived anticancer agents have been dis-
covered through large-scale screening programs [5].
Furthermore, the broad reaching support and continua-
tion of studies of plant extracts with implications in
pancreatic cancer treatment are indicative of the contin-
ued role that natural products play in the drug discovery
process [6,7].
This study provides data on the cytotoxic potential of
56 extracts derived from 44 different plants used in Ban-
gladeshi folk medicine. A three-tiered screening system
was designed, in which all extracts were first screened
for their ability to induce death in the Panc-1 cell line
using a label-free photonic crystal (PC) biosensor assay.
These experiments generated biosensor images of
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tion changes in treated versus untreated cultures. Next,
extracts that showed significant cytotoxicity to Panc-1
cells (>80% cell death at a testing concentration of 100
μg/mL) in the PC biosensor assay were tested using a
colorimetric MTT assay on two additional pancreatic
cell lines (Mia-Paca2, and Capan-1). Toxicity to a nor-
mal foreskin Hs68 fibroblast cell line was studied as a
control. Finally, the extract showing the highest cyto-
toxicity in all three cancer cell lines was evaluated for
its apoptotic activity via a caspase-3 quantification assay.
Methods
Plant materials
Fifty-six plant extracts (Table 1) commonly used in
Bangladeshi folk medicine were kindly provided by
Dr. R. Chowdhury from the University of Dhaka,
Bangladesh, where voucher specimens are maintained.
The plants were collected from the Dhaka, Chittagonga,
and Khulna districts of Bangladesh.
Extraction of plant materials
Details of the extraction process have been described
previously [8]. Briefly, the air-dried and powdered leaves
of each plant were extracted with light petroleum ether,
dichloromethane, ethanol, or methanol. The extraction
method used for each sample that was tested is listed in
Table 1. The extracts were then filtered and the volume
o ft h ef i l t r a t ew a sr e d u c e du s i n gaB u c h i ir o t a r ye v a -
porator at low temperature and pressure. Preliminary
phytochemical screening results and the reported major
constituents of these extracts have been reported [8].
Stock solutions of the extractives were prepared by dis-
solution in ethanol. The final concentrations of the extract
dilutions in culture were 0.1, 1, 10, and 100 μg/mL. The
concentration of ethanol in these dilutions was restricted
to no more than 0.5% (v/v) to minimize potential effects
of the solvent on cell growth. Doxorubicin hydrochloride
(DOX), Curcumin (Cur.), and Staurosporine, used as
positive controls, were purchased from Sigma Aldrich
(St. Louis, MO, USA).
General cell culture methods
Three human pancreatic carcinoma cell lines and were
used in this study: Panc-1, derived from a mostly dif-
ferentiated carcinoma [9]; MIA PaCa-2 (MIA), derived
from an undifferentiated tumor in the pancreas [10];
and Capan-1, derived from liver metastases of a well-
differentiated tumor [11]. The human foreskin fibro-
blast cell line Hs68 was used as a control. All four cell
lines were obtained from ATCC (Rockville, MD, USA).
Cell lines were grown at 37°C and 5% CO2 in sterile
DMEM medium with 10% fetal bovine serum (Panc-1
and Hs68), DMEM with 10% fetal bovine serum and
2.5% horse serum (MIA), and IMDM with 20% fetal
bovine serum (Capan-1), after the addition of 4 mM
L-glutamine and penicillin-streptomycin. Cell culture
media was obtained from the School of Chemical
Sciences Cell Media Facility at the University of Illinois
at Urbana-Champaign. Cells were grown in standard
tissue culture flasks and upon reaching 80% confluence
were passaged with a solution of 0.25% trypsin-EDTA.
Cytotoxicity screening using PC biosensor-based cell
attachment assay
The preliminary determination of the effect of each
plant extract on Panc-1 cells was made in an initial
screen using a label-free PC biosensor-based assay.
Details of the PC biosensor and imaging instrumenta-
tion have been described [12,13]. Briefly, the sensor
operates by measuring local changes in the peak wave-
length value (PWV) of reflected light as cellular binding
events occur in the evanescent field that extends above
the sensor surface. Sheets of the completed sensor are
attached to bottomless 384-well plates. Measurements of
the PWV shifts in a microplate well are made on a
pixel-by-pixel basis to generate PWV images of the
whole well with a spatial resolution of 6.4 μm × 6.4 μm.
T om e a s u r eas h i f ti nt h eP W Vd u et oc e l la t t a c h m e n t ,
the sensor surface is scanned twice: before (baseline
scan) and after cells have attached to the surface (post-
attachment scan). Using the accompanying software, the
two images are aligned and the baseline scan is mathe-
matically subtracted to determine the shift in PWV
values due to cell attachment. This PWV shift is a mea-
sure of the density of cell binding as a function of posi-
tion within the well. This method has been used both to
detect the attachment of individual cells, and to scan
large populations of cells in microplate wells [14,15].
We have also used this assay for cytotoxicity screens,
demonstrating excellent agreement in results between
the PC and MTT assays [16].
To perform the PC biosensor screening assay, an
initial baseline PWV scan was first taken in which
each biosensor microplate well contained 25 μLc e l l
culture media. Following this baseline scan, the media
was aspirated and the cells were then plated into the
wells of a 384-well biosensor microplate at a density of
approximately 500 cells/well and allowed to attach
overnight at 37°C. To verify cell plating uniformity, a
post-attachment scan was taken after cell attachment
and the PWV shift image was determined by subtract-
ing the baseline image from the post-attachment
image. The cells were then incubated for 24 hours
with 25 μL of extract in media at a final concentration
of 100 μg/mL. Control cultures and blank wells with-
out cells received 100 μL of medium with 0.5% (v/v) of
ethanol. After the 24 h drug exposure period, the cells
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Page 2 of 11Table 1 The names of the 56 plant extracts screened in this study
Extract
No. Plant Family Name Extract/partitionate
Fraction of Panc-1 cell
survival
1 Aglaia roxburghiana Kurz Meliaceae n-Hexane partitionate of MeOH extract 0.02 ± 0.00
2 Alternanthera sessilis DC. Amaranthaceae Pet-ether fraction of MeOH extract 0.43 ± 0.14
3 Alternanthera sessilis DC. Amaranthaceae MeOH residue of MeOH extract 1.63 ± 0.41
4 Alternanthera sessilis DC. Amaranthaceae CHCl3 fraction of MeOH extract 0.04 ± 0.09
5 Amoora chittagonga Hiern Meliaceae Pet-ether partitionate of MeOH extract 0.36 ± 0.17
6 Amoora chittagonga Hiern Meliaceae CHCl3 partitionate of MeOH extract 0.02 ± 0.01
7 Amoora chittagonga Hiern Meliaceae EtOAc partitionate of MeOH extract 2.38 ± 0.35
9 Amoora rohituka (Roxb.) Wight & Arn. Meliaceae Pet-ether extract 0.10 ± 0.02
10 Amoora rohituka (Roxb.) Wight & Arn. Meliaceae MeOH extract 0.79 ± 0.18
11 Anisoptera glabra Kurz Dipterocarpaceae MeOH extract 3.18 ± 0.18
12 Anogeissus latifolia (Roxb.) Bedd Combretaceae EtOH extract 0.18 ± 0.06
13 Brunfelsia americana L. Solanaceae MeOH extract 0.79 ± 0.14
14 Brunfelsia latifolia Hort. ex. Steud. Solanaceae MeOH extract 1.46 ± 0.27
15 Buchanania lanzen Spreng. Anacardiaceae MeOH extract 0.23 ± 0.11
16 Bursera serrata Wall. ex. Coleb. Burseraceae Pet-ether extract 0.01 ± 0.01
17 Bursera serrata Wall. ex. Coleb. Burseraceae Dichloromethane extract 0.07 ± 0.03
18 Chukrasia tabularis Juss. Meliaceae MeOH extract 0.21 ± 0.11
19 Cinnamomum zeylanicum Blume Lauraceae MeOH extract 0.59 ± 0.15
20 Citrus hystrix DC. Rutaceae MeOH extract 0.02 ± 0.01
21 Combretum coccineum Engl. & Diels Combretaceae CHCl3 partitionate of acidified MeOH extract 0.35 ± 0.12
22 Combretum grandiflorum G.Don Combretaceae MeOH extract 1.15 ± 0.23
23 Eclipta prostrata L. Asteraceae MeOH extract 0.50 ± 0.03
24 Erioglossum edule Blume Sapindaceae MeOH extract 0.93 ± 0.03
25 Ficus indica L. Moraceae MeOH extract 0.57 ± 0.08
26 Garuga pinnata Roxb. Burseraceae MeOH extract 0.60 ± 0.19
27 Indigofera tinctoria L. Papilionaceae EtOH extract 0.77 ± 0.26
28 Lannea coromandelica (Houtt.) Merr. Anacardiaceae MeOH extract 2.44 ± 0.15
29 Nephelium litchi Sonn. Sapindaceae MeOH extract 0.27 ± 0.11
30 Nephelium longan (Lour.) Hook Sapindaceae MeOH extract 0.75 ± 0.19
31 Pesprum nocturnum L. Solanaceae MeOH extract 0.10 ± 0.02
32 Petunia meleagris Planch. Solanaceae MeOH extract 1.26 ± 0.29
33 Petunia phoenicea H.Jacq. Solanaceae MeOH extract 0.66 ± 0.22
34 Petunia punctata Paxton Solanaceae MeOH extract 0.08 ± 0.04
35 Petunia violaceae Lindl. Solanaceae MeOH extract 0.46 ± 0.16
37 Phyllanthus reticulatus Lodd. Euphorbiaceae CHCl3 fraction of pet-ether extract 0.03 ± 0.01
38 Phyllanthus reticulatus Lodd. Euphorbiaceae Hexane fraction of CH2Cl2 extract 0.60 ± 0.26
39 Phyllanthus reticulatus Lodd. Euphorbiaceae Acidified CHCl3 fraction of aqueous extract 1.25 ± 0.31
40 Phyllanthus reticulatus Lodd. Euphorbiaceae Acetone extract 1.36 ± 0.21
41 Poivrea coccinea DC. Combretaceae MeOH extract 0.04 ± 0.01
42 Pongamia glabra Vent. Leguminosea MeOH extract 0.14 ± 0.07
43 Protium serratum Engl. Burseraceae MeOH extract 1.65 ± 0.12
44 Pterospermum suberifolium Willd. Sterculiaceae MeOH extract 0.59 ± 0.06
45 Quisqualis indica L. Combretaceae Pet-ether extract 1.19 ± 0.31
46 Quisqualis indica L. Combretaceae MeOH extract 1.07 ± 0.24
47 Sapindus mukorossi Gaertn. Sapindaceae MeOH extract 1.57 ± 0.18
48 Semecarpus anacardium L.f. Anacardiaceae MeOH extract 2.10 ± 0.05
49 Shorea robusta C.F.Gaertn. Dipterocarpaceae EtOH extract 0.48 ± 0.16
52 Spondias mangifera Willd. Anacardiaceae MeOH extract 1.83 ± 0.14
53 Swintonia floribunda Griff. Anacardiaceae MeOH extract 2.92 ± 0.17
54 Terminalia bellerica Roxb. Combretaceae MeOH extract 0.22 ± 0.05
55 Terminalia bellerica Roxb. Combretaceae MeOH extract 1.64 ± 0.26
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medium. Finally, a post-treatment scan was taken and
the PWV shift image was determined by subtracting
the baseline image from the post-treatment image.
Increases in the local PWV as registered by the local
pixels were observed only in regions where cells
formed a close physical attachment to the sensor sur-
face. Dead cells and other debris that are physically
deposited on the same surface did not register similar
increases in the local PWV. Estimates of the number
of the cells that were attached to the sensor surface in
each well were made using a PWV shift threshold as
described earlier [17]. Cell counts were determined for
all wells after incubation with the extracts and prolif-
eration was expressed as the fraction of treated cells
that survived relative to untreated cultures. Every
experiment included a set of negative controls
(untreated cultures) as well as two sets of positive con-
trols (DOX and Curcumin). All experiments were per-
formed in triplicate.
MTT proliferation assay
The MTT assay was used to confirm the results of the
initial PC-based screen and test identified leads on three
additional cell lines. Changes in proliferation rates of
cells treated with various plant extracts were determined
using the ATCC MTT Cell Proliferation Assay kit. The
assay, previously described [18], is based on the conver-
sion of yellow tetrazolium salt MTT to purple formazan
crystals by metabolically active cells. The amount of for-
mazan produced is proportional to the number of viable
cells.
Cells were plated in 96-well flat bottom tissue culture
plates at a density of approximately 1-1.2 × 10
4 cells/
well and allowed to attach overnight at 37°C. The cells
were then incubated with 100 μL of an extract at a con-
centration of 100 μg/mL for 24 hours. Untreated cul-
tures and blank wells without cells received 100 μLo f
medium with 0.5% (v/v) of ethanol. After the drug expo-
sure period, the cells were grown for an additional
24 hours in extract-free fresh medium. Next, 10 μLo f
the MTT reagent was added to each well, and the plate
was incubated for 4 hours at 37°C. The MTT crystals
were then solubilized overnight by adding 100 μLo ft h e
MTT detergent reagent to each well. Absorbance mea-
surements were made at 570 nm using a Biotek® Synergy
HT Spectrophotometer. Proliferation was expressed as
the fraction of treated cells that survived relative to
untreated cultures. The IC50 values were calculated
using GraphPad Prism 5.0 (GraphPad Software Inc.,
S a nD i e g o ,C A ) .E v e r ye x p e r i m e n ti n c l u d e das e to f
negative controls (untreated cultures) as well as two sets
of positive controls (DOX and Curcumin). All experi-
ments were performed in triplicate and repeated at
least twice.
Caspase-3 activity quantification assay
Caspase-3 activity was assessed using the caspase-3 Colori-
metric Assay Kit (Sigma Aldrich), following the manufac-
turer’s instructions. This assay is based on the detection of
the amount of Ac-DEVD-p-NA substrate cleaved by cell
lysates to release the colored p-NA molecule. Here,
PANC-1 cells were exposed to the P. punctata extract
(100 μg/mL) or Staurosporine (0.1 μg/mL), a known apop-
totic agent. Following treatment, the cells were washed in
PBS and suspended in a lysis buffer (50 mM HEPES pH
7.4, 5 mM CHAPS, 5 mM DTT) for 15 minutes at a con-
centration of 10
7 cells per 100 μL of buffer. Lysed cells
were centrifuged at 16,000 × g, 4°C for 15 minutes. Lysate
protein concentrations were determined using the Brad-
ford assay. Equal amounts of protein (~ 20 μg) from each
sample were added to wells containing the assay buffer
(20 mM HEPES, pH 7.4, 0.1% CHAPS, 5 mM DTT, 2 mM
EDTA), followed by 10 μlo fA c - D E V D - p-NA (20 mM),
bringing the total volume of each well to 100 μl. Caspase-
3 activity was assessed by measuring the optical density at
405 nm using a Biotek® Synergy HT Spectrophotometer.
The amount of Ac-DEVD-pNA cleaved was then calcu-
lated and plotted. The effect of Ac-DEVD-CHO, a cas-
pase-3 inhibitor, on caspase-3 activity was studied
simultaneously. As per the manufacturer’s instructions,
10 μl of the inhibitor Ac-DEVD-CHO (2 mM) was added
Table 1 The names of the 56 plant extracts screened in this study (Continued)
56 Trachyspermum ammi Sprague Umbelliferae EtOH extract 1.04 ± 0.18
57 Xanthoxylum budrunga DC. Rutaceae MeOH residue of MeOH extract 0.55 ± 0.05
59 Xylocurpus molucensis (Lamarck) M.
Roemer
Meliaceae n-Hexane partitionate of MeOH extract 1.12 ± 0.05
60 Xylocurpus molucensis (Lamarck) M.
Roemer
Meliaceae MeOH residue of MeOH extract 0.62 ± 0.18
61 Zizyphus jujuba Mill. Rhamnaceae MeOH extract 0.90 ± 0.19
The last column presents the anti-proliferative activity of each extract and the top nine cytotoxic extracts are in bold*.
*The PC biosensor was used to screen this library for extracts with anti-proliferative properties and the results are presented as the fraction of Panc-1 (human
pancreatic cancer) cell survival relative to untreated controls after exposure to the plant extract. A testing concentration of 100 μg/mL and exposure time of 24
hours was used. Mean ± S.D. values of three replicates are reported here.
George et al. BMC Complementary and Alternative Medicine 2010, 10:52
http://www.biomedcentral.com/1472-6882/10/52
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by the cell lysate and 10 μl of the substrate Ac-DEVD-
pNA (20 mM). All experiments were performed in dupli-
cate and repeated at least twice.
Statistical analysis
Results were expressed as means ± SD of replicates.
Comparison between data sets was performed using one
way analysis of variance (ANOVA) followed by Student’s
t-test. All statistical analyses were performed using
GraphPad Prism 5.0 (GraphPad Software Inc., San
Diego, CA). Differences were accepted as statistically
significant at p < 0.05.
Results
Cytotoxicity screening on Panc-1 cells
An initial screen of fifty-six extracts was performed on
the Panc-1 cell line using the PC biosensor-based cell
attachment assay. Biosensor images of representative
individual wells of a 384-well biosensor microplate
before and after treatment are shown in Figure 1. Here,
the PWV shift as a function of position is represented
as a false color image in which each pixel represents a
6.4 μm × 6.4 μm region of the sensor surface. Figure 1a
shows the PWV shift images of an untreated control
well taken before and after the treatment period. Figures
1b-c show PWV shift images of the two positive control
wells, DOX and Curcumin, taken before and after the
treatment period. Figure 1d shows PWV shift images of
cells treated with P. punctata (No. 34) where nearly
100% cell death was observed. Finally, Figure 1e shows
PWV shift images of cells treated with A. glabra
(No. 11) where the extract enhanced cell proliferation.
Using the thresholding method, the number of cells in
each well after the initial seeding period was determined
from the top PWV shift image. After the treatment per-
iod, cell counts for each well were obtained from the
bottom PWV shift image and counts from treated wells
were compared against those from untreated control
wells present on the same plate. The data from PWV
shift images of the 56 extracts were converted into cell
survival fractions relative to untreated wells as shown in
Figure 2. Twenty-two of the plant extracts induced over
50% death of Panc-1 cells at a treatment concentration
of 100 μg/mL (Table 1). The top nine cytotoxic extracts
induced over 80% cell death.
Cytotoxicity assay on two additional cancer cell lines and
one fibroblast cell line
The nine extracts identified in the PC-based screen were
then tested using the MTT assay on the Capan-1, and
MIA cell lines, in addition to the Panc-1 cells. Four of
these extracts (Nos. 4, 6, 34, 41) induced over 50%
death in the MIA and Capan-1 cell lines (Figure 3). The
three most potent extracts identified - P. punctata (No.
34), A. sessilis (No. 4), and A. chittagonga (No. 6) - were
found to induce over 70% cell death in all three cell
lines. Dose response studies of these three extracts on
three cancer cell lines and one fibroblast cell line (Hs68)
are presented in Figure 4 and IC50 values are summar-
ized in Table 2. The P. punctata extract had IC50 values
of 20.34 μg/mL, 24.97 μg/mL, and 31.39 μg/mL for
Panc-1, MIA, and Capan-1, respectively. However, this
extract was also toxic to Hs68 cells with an IC50 value
of 25.81 μg/mL. Similarly, the A. sessilis (No. 4) extract
showed high cytotoxicity to the cancer cell lines with
IC50 values in the 13.08 μg/mL - 34.92 μg/mL range but
limited selectivity. In contrast, A. chittagonga (No.6)
showed high cytotoxicity to all cancer cells (IC50 of 42.8
μg/mL - 49.8 μg/mL) and low cytotoxicity to the fibro-
blast cells (IC50 > 100 μg/mL).
Extract induces apoptosis
Caspase-3 activation is a crucial component in the apop-
totic signaling cascade. Although P. punctata (No. 34)
was not selectively cytotoxic to pancreatic cancer cells,
we were interested to see if the observed high cytotoxi-
city to Panc-1 cells treated with P. punctata was
mediated via apoptosis. To further elucidate the
mechanism of cell death induced by P. punctata, a cas-
pase-3 colorimetric assay was conducted to establish the
levels of caspase-3 activation both before and after treat-
ment with the extract. The results of this experiment
show that treatment of Panc-1 cells with P. punctata
strongly induces increased caspase-3 activity (Figure 5a).
Next, we were interested in comparing the level of P.
punctata-induced caspase-3 activity to that induced by
one of our positive controls. Staurosporine was chosen
as an appropriate positive control. It is of note that, at a
testing concentration of 100 ug/mL and exposure time
of 24 hours, both Staurosprine (fraction of cell survival
= 0.07 ± 0.02) and Curcumin exhibited the same level
of cytotoxicity on Panc-1 cells as measured through an
MTT assay. Figure 5b shows that the caspase-3 activity
observed in cells treated with P. punctata was similar to
that observed with Staurosporine-treated cells. In con-
trast, untreated controls were shown to maintain a basal
caspase-3 activity (Figure 5b). Furthermore, caspase-3
activity in P. punctata-treated cells was reduced in the
presence of a caspase-3 specific apoptosis inhibitor,
Ac-DEVD-CHO. This suggests the involvement of cas-
pase-3 in triggering apoptosis in P. punctata-treated
Panc-1 cells. Complete inhibition of caspase-3 activity
was not observed; this was to be expected, given
the brevity of the inhibitor-lysate incubation and the
presence of the substrate in 10-fold excess.
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Page 5 of 11Figure 1 PWV shift images in false color with shift scale bars indicating the magnitude of wavelength shifts in nanometers. Pixels with
higher PWV displayed in brighter colors, indicate locations where Panc-1 cell attachment has occurred. The five image sets represent the
following (a) untreated control, (b) positive control (DOX), (c) positive control (Curcumin), (d) extract that induced 100% cell death (P. punctata,
No. 34), (e) extract that enhanced proliferation (A. glabra, No. 11). In each image set, the top image was taken before exposure and the bottom
image was taken after the 24 hour exposure period with a plant extract or positive control at 100 μg/mL. Scale bar (white) = 300 μm.
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Due to the high mortality rates of pancreatic cancer and
the absence of effective chemotherapy, there is a contin-
ued need for new alternatives for treatment and preven-
tion, and natural products play a dominant role in the
discovery of such new drugs [7,19]. In this report, we
screened a library of plants native to Bangladesh, many
of which are used in Bangladeshi folk medicine for
treating a variety of ailments, including cancer. We have
used a label-free biosensor assay in conjunction with
traditional colorimetric proliferation and caspase-3 activ-
ity assays, for identifying new natural-product based
leads with high cytotoxicity to pancreatic cancer cells.
Three human pancreatic adenocarcinoma cell lines
(Panc-1, MIA, and Capan-1) were studied as an in vitro
model due to both their reported low sensitivity to a
current treatment agent (Gemcitabine) and their expres-
sion of multiple drug resistant proteins [20-23]. Our
experimental results confirmed the drug resistant prop-
erties of these cells; Gemcitabine exhibited no
Figure 3 Subsequent MTT cell viability tests on two additional pancreatic cancer cell lines revealed that four plant extracts (Nos. 4, 6,
34, and 41) were able to suppress proliferation in all three strains. Reported mean ± S.D. values are from a representative trial out of two
or more trials.
Figure 2 56 plant extracts were screened for their ability to induce Panc-1 cell death using the PC biosensor assay to determine the
fractions of cell surviving after 24 h exposure to the extract. Dox and Curcumin are the positive controls. Nine extracts induced > 80% cell
death. Data represents mean ± S.D. values of three replicates.
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Page 7 of 11cytotoxicity toward Panc-1 cells at a testing concentra-
tion of 100 μg/mL (data not shown). Hence, we did not
use Gemcitabine as a positive control in our screen.
At a testing concentration of 100 μg/mL, 22 of the 56
extracts reduced Panc-1 cell survival by more than 50%
(Table 1 and Figure 2). Upon expanding testing to a panel
of two additional pancreatic cancer cell lines and one
fibroblast cell line, the following three extracts were found
to significantly reduce pancreatic cancer cell proliferation:
P. punctata (No. 34), A. sessilis (No. 4), and A. chittagonga
(No. 6). While all three extracts showed low cytotoxicity
to fibroblast cells at low concentrations (<20 μg/mL), only
A. chittagonga continued to exhibit low cytotoxicity at
elevated concentrations (Figures 3 and 4).
P. punctata was found to show high cytotoxicity against
the cancer cell panel. Morphological changes observed in
treated cells suggest the induction of cellular apoptosis,
which was confirmed by a biochemical assay verifying
increased expression of caspase-3 protein in cells treated
with P. punctata (Figure 5). Interestingly, this study is
not the first instance in which the species P. punctata
(a member of the Solanaceae family) has been associated
with potential pharmacological activity. The results of a
phytochemical screening of the methanolic extract of
P. punctata showed the presence of steroids as an active
component [8]. Moreover, several additional species of
the Solanaceae family are currently used for the treat-
ment of infections and skin disorders [24]. P. punctata
has also been shown to possess strong antimicrobial
activity [25]. In addition, separate studies have reported
Figure 4 Growth inhibitory effects of (A) Petunia punctata (No. 34), (B) Althernanthera sessilis (No. 4), and (C) Amoora chittagonga (No.
6) on the three pancreatic cancer cell lines, Panc-1, MIA, and Capan-1, and a human fibroblast cell line, Hs68. Proliferation suppression
appears to be dose dependant. Reported mean ± S.D. values are from a representative trial out of two or more trials.
Table 2 IC50 values of P. punctata (Extract No. 34),
A. sessilis (No. 4) and A. chittagonga (No. 6) for human
pancreatic cancer and human foreskin fibroblast cell
lines.
Cell line IC50 (μg/mL)
P. punctata
(No. 34)
A. sessilis
(No. 4)
A. chittagonga
(No. 6)
Panc-1 20.34 ± 13.99 27.19 ± 3.01 48.60 ± 4.59
MIA 24.97 ± 4.59 13.08 ± 10.40 42.79 ± 5.88
Capan-1 31.39 ± 2.91 34.92 ± 2.20 49.82 ± 11.60
Hs68 25.81 ± 0.44 32.82 ± 10.74 > 100
Mean ± S.D. values of two or more independent trials are reported below.
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ceae family on several human cancer cell lines [26,27].
Similar to P. punctata, A. sessilis has shown promise
in relatively disparate areas of medicine. A member of
the Amaranthaceae family, A. sessilis has a history of
u s ei nI n d i a na n dC h i n e s et r a d i t i o n a lm e d i c i n e[ 2 7 ] .
Preparations of this plant have been shown to possess
anti-microbial properties, in addition to speeding the
wound-healing process [27]. A recent study has also
demonstrated the hepatoprotective effects of this plant
in a rat model [28,29]. However, this represents the first
instance in which the therapeutic potential of A. sessilis
in cancer treatment has been reported.
Finally, Amoora chittagonga belongs to the Meliaceae
family. A few Amoora species have been shown to pos-
sess anti-inflammatory, anti-cancer, and hepatoprotective
medicinal properties [30]. The compound amooranin,
extracted from the bark of an extensively studied Amoora
species (A. rohituka) has been shown to induce apoptosis
in breast carcinoma through caspase activation [31].
Furthermore, this compound is known to be effective
against a broad panel of cancer cell lines, including colon
cancer, cervical cancer, and leukemia [32]. However,
there are currently no reports on the medicinal properties
of the A. chittagonga.W ef o u n dt h a tA. chittagonga
showed anti-proliferative properties in several models of
pancreatic cancer, while maintaining low toxicity to non-
cancerous Hs68 fibroblast cells.
While not the primary focus of this work, it is worth-
while to discuss some of the advantages afforded by the
PC biosensor system in our cell-based screening assays.
Since these biosensors are incorporated into micro-
plates, they can be used with standard microplate liquid
handling instrumentation such as pipetting systems and
wash stations. Furthermore, assays using as few as 500
Panc-1 cells per well in a 384-well plate can be per-
formed, which is particularly important for cell lines
that proliferate slowly. A comparable colorimetric based
MTT proliferation assay requires 2500-3000 cells per
well. Although the assays shown in this work utilize
cells that readily attach to the biosensor surface without
the use of specific capture molecules, previous work has
also demonstrated the use of PC biosensors for cells
that would ordinarily remain suspended in solution by
preparing the biosensor with immobilized proteins that
specifically bind with outer membrane proteins [14]. We
have previously demonstrated high correlation between
results from the PC-based cell assay and the comparable
MTT assay [16].
Since PC biosensor assays are label-free, cells are not
stained, killed, or altered in any way. Hence, it is possible
to use the biosensor to perform proliferation assays, and
to subsequently use the same cells to interrogate the pre-
sence of a protein, such as caspase-3. Caspase-3 protein
detection and quantification can be performed using
c o m m e r c i a l l ya v a i l a b l ek i t sd e s i g n e dt ow o r kd i r e c t l yw i t h
cultures of adherent cells. One such test (Caspase-Glo®
from Promega, WI, USA) uses a single reagent to per-
form both the cell lysis and the caspase cleavage of a sub-
strate leading to the generation of luminescence, which is
detectable using any standard microplate-compatible
spectrophotometer. Such additional interrogation allows
much more information to be derived from a single cul-
ture of cells, thereby decreasing the role of biological
variability on the results of a given trial, experiment, or
screening assay.
Figure 5 (A) Caspase-3 activity of Panc-1 cells treated with 100
μg/ml of Petunia punctata (No. 34). (B) Caspase-3 activity of
lysates from untreated, 34-treated, and Staurosporine treated Panc-1
cells in the absence and presence of a caspase-3 inhibitor
(Ac-DEVD-CHO). Treatment period lasted three hours.
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In this work, we screened 56 extracts of 44 unique Ban-
gladeshi medicinal plants for their anti-proliferative
properties in three cultured pancreatic cancer cell lines.
Screening of each of the extracts identified three
extracts with the desired properties. Further testing
revealed one extract to induce high toxicity to multiple
cancerous cell lines while preserving relatively low levels
of toxicity toward a non-cancerous control cell line. Our
results provide the basis for the further investigation of
each of these species and potential identification of
novel bioactive compounds with therapeutic, anti-cancer
properties. Elucidating the mechanisms by which these
anti-cancer properties are derived from the plant
extracts is of crucial importance. Such clarification is
necessary to identify, select for, and optimize therapeutic
compounds. Though naturally occurring compounds
such as those found in P. punctata, A. sesselis,a n d
A. chittagonga often provide excellent starting points,
deriving the mechanistic advantages of such compounds
will allow the development and realization of specific,
highly potent anti-cancer drugs with limited peripheral
toxicity.
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